Invention Grant
US08663645B2 Use of native peptides and their optimized derivatives for vaccination
有权
使用天然肽及其优化的衍生物进行疫苗接种
- Patent Title: Use of native peptides and their optimized derivatives for vaccination
- Patent Title (中): 使用天然肽及其优化的衍生物进行疫苗接种
-
Application No.: US11913138Application Date: 2006-05-09
-
Publication No.: US08663645B2Publication Date: 2014-03-04
- Inventor: Kostantinos (Kostas) Kosmatopoulos
- Applicant: Kostantinos (Kostas) Kosmatopoulos
- Applicant Address: FR Evry Cedex
- Assignee: Vaxon Biotech
- Current Assignee: Vaxon Biotech
- Current Assignee Address: FR Evry Cedex
- Agency: Alston & Bird
- Priority: EP05290984 20050509
- International Application: PCT/EP2006/005325 WO 20060509
- International Announcement: WO2006/120038 WO 20061116
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/12 ; A61K38/00 ; A61K38/08
Abstract:
The present invention pertains to the field of vaccination, and more particularly to the fields of antitumor and antiviral vaccination. The invention relates to the use of a native peptide in a medicinal composition, for selecting and/or boosting part of a CTL immune response which has been initiated by an optimized immunogenic peptide derived from said native peptide. The invention also concerns vaccination kits which comprise several doses of optimized peptides and of their cognate native peptides.
Public/Granted literature
- US20080254051A1 Use of Native Peptides and Their Optimized Derivatives For Vaccination Public/Granted day:2008-10-16
Information query
